The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...

Eli Lilly is just weeks away from launching Mounjaro in the UK, after getting approval from medicines regulator, the MHRA, for a new formulation of the drug as a treatment for diabetes and obesity.

Mazdutide – a once-weekly injectable Innovent licensed from Lilly – was submitted ... in Chinese adults with type 2 diabetes inadequately controlled by diet and exercise alone had met the ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Eli Lilly (NYSE: LLY) has emerged as one of the hottest stocks in the GLP-1 realm -- underscored by its combination of ...

Eli Lilly's pill works in a similar way to Wegovy, Ozempic, and Novo Nordisk's diabetes pill Rybelsus, targeting a gut hormone called GLP-1 to suppress a person's appetite and regulate blood sugar.

With approximately 101 million individuals living with diabetes, increasing access to insulin and advanced treatments is ...